Ortega P, Bournique E, Li J, Sanchez A, Santiago G, Harris B
bioRxiv. 2024; .
PMID: 39605722
PMC: 11601322.
DOI: 10.1101/2024.11.14.623607.
Islam M, Al-Jassas R, Al-Majid A, Haukka M, Nafie M, Abu-Serie M
RSC Med Chem. 2024; 15(8):2937-2958.
PMID: 39149093
PMC: 11324055.
DOI: 10.1039/d4md00337c.
Magrath J, Espinosa-Cotton M, Flinchum D, Sampath S, Cheung N, Lee S
Front Cell Dev Biol. 2024; 12:1442488.
PMID: 39139449
PMC: 11319132.
DOI: 10.3389/fcell.2024.1442488.
Rowland R, Korolchuk S, Salamina M, Tatum N, Ault J, Hart S
Nat Commun. 2024; 15(1):6807.
PMID: 39122719
PMC: 11316097.
DOI: 10.1038/s41467-024-51135-w.
Aumer T, Dather M, Bergmayr L, Kartika S, Zeng T, Ge Q
Life Sci Alliance. 2024; 7(9).
PMID: 38906675
PMC: 11192838.
DOI: 10.26508/lsa.202302437.
Multi-step control of homologous recombination via Mec1/ATR suppresses chromosomal rearrangements.
Xie B, Sanford E, Hung S, Wagner M, Heyer W, Smolka M
EMBO J. 2024; 43(14):3027-3043.
PMID: 38839993
PMC: 11251156.
DOI: 10.1038/s44318-024-00139-9.
Development of a PROTAC Targeting Chk1.
Roy Chowdhury S, Chuong P, Mgbemena V, Statsyuk A
bioRxiv. 2024; .
PMID: 38260247
PMC: 10802242.
DOI: 10.1101/2023.12.30.573733.
An RNAi screen for conserved kinases that enhance microRNA activity after dauer in Caenorhabditis elegans.
Roka Pun H, Karp X
G3 (Bethesda). 2024; 14(3).
PMID: 38226857
PMC: 10917497.
DOI: 10.1093/g3journal/jkae007.
Identification of Tumor-Suppressive Regulated Genes: as a Therapeutic Target in Lung Adenocarcinoma.
Hagihara Y, Tomioka Y, Suetsugu T, Shinmura M, Misono S, Goto Y
Cancers (Basel). 2023; 15(23).
PMID: 38067275
PMC: 10705761.
DOI: 10.3390/cancers15235571.
Mammalian cells internalize bacteriophages and use them as a resource to enhance cellular growth and survival.
Bichet M, Adderley J, Avellaneda-Franco L, Magnin-Bougma I, Torriero-Smith N, Gearing L
PLoS Biol. 2023; 21(10):e3002341.
PMID: 37883333
PMC: 10602308.
DOI: 10.1371/journal.pbio.3002341.
CHK1-CDC25A-CDK1 regulate cell cycle progression and protect genome integrity in early mouse embryos.
Knoblochova L, duricek T, Vaskovicova M, Zorzompokou C, Rayova D, Ferencova I
EMBO Rep. 2023; 24(10):e56530.
PMID: 37694680
PMC: 10561370.
DOI: 10.15252/embr.202256530.
Cardiac regeneration: Pre-existing cardiomyocyte as the hub of novel signaling pathway.
Wang T, Chen X, Wang K, Ju J, Yu X, Yu W
Genes Dis. 2023; 11(2):747-759.
PMID: 37692487
PMC: 10491875.
DOI: 10.1016/j.gendis.2023.01.031.
Hornerin mediates phosphorylation of the polo-box domain in Plk1 by Chk1 to induce death in mitosis.
Song H, Kim E, Hong J, Gwon D, Kim J, Bae G
Cell Death Differ. 2023; 30(9):2151-2166.
PMID: 37596441
PMC: 10482915.
DOI: 10.1038/s41418-023-01208-y.
A multi-scale map of protein assemblies in the DNA damage response.
Kratz A, Kim M, Kelly M, Zheng F, Koczor C, Li J
Cell Syst. 2023; 14(6):447-463.e8.
PMID: 37220749
PMC: 10330685.
DOI: 10.1016/j.cels.2023.04.007.
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
Kristeleit R, Plummer R, Jones R, Carter L, Blagden S, Sarker D
Br J Cancer. 2023; 129(1):38-45.
PMID: 37120671
PMC: 10307885.
DOI: 10.1038/s41416-023-02279-x.
Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer.
Kim H, Seo B, Seo E, Lee K, Hwangbo C
Curr Issues Mol Biol. 2022; 44(12):5848-5865.
PMID: 36547059
PMC: 9777496.
DOI: 10.3390/cimb44120398.
Construction of a Versatile, Programmable RNA-Binding Protein Using Designer PPR Proteins and Its Application for Splicing Control in Mammalian Cells.
Yagi Y, Teramoto T, Kaieda S, Imai T, Sasaki T, Yagi M
Cells. 2022; 11(22).
PMID: 36428958
PMC: 9688318.
DOI: 10.3390/cells11223529.
In Silico Studies on GCP-Lys-OMe as a Potential 14-3-3σ Homodimer Stabilizer.
Aljabal G, Yap B
Pharmaceuticals (Basel). 2022; 15(10).
PMID: 36297403
PMC: 9609495.
DOI: 10.3390/ph15101290.
Safeguarding DNA Replication: A Golden Touch of MiDAS and Other Mechanisms.
Al Ahmad Nachar B, Rosselli F
Int J Mol Sci. 2022; 23(19).
PMID: 36232633
PMC: 9570362.
DOI: 10.3390/ijms231911331.
Inhibition of Chk2 promotes neuroprotection, axon regeneration, and functional recovery after CNS injury.
Taylor M, Thompson A, Alhajlah S, Tuxworth R, Ahmed Z
Sci Adv. 2022; 8(37):eabq2611.
PMID: 36103534
PMC: 9473583.
DOI: 10.1126/sciadv.abq2611.